Bruining, H A
495  Ergebnisse:
Personensuche X
?
 
?
4

P.130 Bumetanide versus placebo for core symptoms of autism..:

Sprengers, J. ; Van Andel, D. ; Zuithoff, N....
European Neuropsychopharmacology.  40 (2020)  - p. S80-S81 , 2020
 
?
5

Efficacy and safety of certolizumab pegol for Crohn's disea..:

Moon, W. ; Pestana, L. ; Becker, B....
Alimentary Pharmacology & Therapeutics.  42 (2015)  4 - p. 428-440 , 2015
 
?
6

Magnetic resonance enterography is feasible and reliable in..:

Coimbra, A. J. F. ; Rimola, J. ; O'Byrne, S....
Alimentary Pharmacology & Therapeutics.  43 (2015)  1 - p. 61-72 , 2015
 
?
7

Radiographical evaluation of ulcerative colitis:

Deepak, P. ; Bruining, D. H.
Gastroenterology Report.  2 (2014)  3 - p. 169-177 , 2014
 
?
 
?
 
?
11

Natalizumab for moderate to severe Crohn's disease in clini..:

Kane, S. V. ; Horst, S. ; Sandborn, W. J....
Inflammatory Bowel Diseases.  18 (2012)  12 - p. 2203-2208 , 2012
 
?
12

Anti‐tumour necrosis factor treatment of inflammatory bowel..:

Mohabbat, A. B. ; Sandborn, W. J. ; Loftus Jr, E. V...
Alimentary Pharmacology & Therapeutics.  36 (2012)  6 - p. 569-574 , 2012
 
?
14

P.4.007 Human schizophrenia and autism candidate gene neure..:

Laarakker, M.C. ; Reinders, N.R. ; Bruining, H...
European Neuropsychopharmacology.  21 (2011)  - p. S83-S84 , 2011
 
?
15

P.2.11 Gene function in social and non-social memory:

Bruining, H. ; van Engeland, H. ; Oppelaar, H...
European Neuropsychopharmacology.  18 (2008)  - p. s45-s46 , 2008
 
1-15